CHMP rejects two drugs - three get endorsement
Minoryx Therapeutics and Apellis got a cold shoulder from the CHMP, the European Medicines Agency’s expert committee for the evaluation of medicinal products.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.